SLNSW-Remdesivir in adults with severe COVID-19: a rand...-TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7190303

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

Full title: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

Author/creator: Wang, Yeming, Zhang, Dingyu, Du, Guanhua, Du, Ronghui, Zhao, Jianping, Jin, Yang, Fu, Shouzhi, Gao, Ling, Cheng, Zhenshun, Lu, Qiaofa, Hu, Yi, Luo, Guangwei, Wang, Ke, Lu, Yang, Li, Huadong, Wang, Shuzhen, Ruan, Shunan, Yang, Chengqing, Mei, Chunlin, Wang, Yi, Ding, Dan, Wu, Feng, Tang, Xin, Ye, Xianzhi, Ye, Yingchun, Liu, Bing, Yang, Jie, Yin, Wen, Wang, Aili, Fan, Guohui, Zhou, Fei, Liu, Zhibo, Gu, Xiaoying, Xu, Jiuyang, Shang, Lianhan, Zhang, Yi, Cao, Lianjun, Guo, Tingting, Wan, Yan, Qin, Hong, Jiang, Yushen, Jaki, Thomas, Hayden, Frederick G, Horby, Peter W, Cao, Bin, Wang, Chen.

Call Numbers:

Record Identifier: TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7190303

Language: English

Formats: Articles

Publishers: England: Elsevier Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7190303

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

    Record identifier

    TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7190303

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7190303

    Share

    Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7190303

    Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

    Full title

    Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

    Author / Creator

    Wang, Yeming ; Zhang, Dingyu ; Du, Guanhua ; Du, Ronghui ; Zhao, Jianping ; Jin, Yang ; Fu, Shouzhi ; Gao, Ling ; Cheng, Zhenshun ; Lu, Qiaofa ; Hu, Yi ; Luo, Guangwei ; Wang, Ke ; Lu, Yang ; Li, Huadong ; Wang, Shuzhen ; Ruan, Shunan ; Yang, Chengqing ; Mei, Chunlin ; Wang, Yi ; Ding, Dan ; Wu, Feng ; Tang, Xin ; Ye, Xianzhi ; Ye, Yingchun ; Liu, Bing ; Yang, Jie ; Yin, Wen ; Wang, Aili ; Fan, Guohui ; Zhou, Fei ; Liu, Zhibo ; Gu, Xiaoying ; Xu, Jiuyang ; Shang, Lianhan ; Zhang, Yi ; Cao, Lianjun ; Guo, Tingting ; Wan, Yan ; Qin, Hong ; Jiang, Yushen ; Jaki, Thomas ; Hayden, Frederick G ; Horby, Peter W ; Cao, Bin ; Wang, Chen

    Publisher

    England: Elsevier Ltd

    Journal title

    The Lancet (British edition), 2020, Vol.395 (10236), p.1569-1578

    Record Identifier

    TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7190303

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Adenosine Monophosphate - adverse effects Adenosine Monophosphate - analogs & derivatives Adenosine Monophosphate - therapeutic use Adults Aged Alanine - adverse effects Alanine - analogs & derivatives Alanine - therapeutic use Analysis Animal models Antiviral Agents - adverse effects Antiviral Agents - therapeutic use Antiviral drugs Betacoronavirus Blood pressure China Clinical trials Coronaviridae Coronavirus Infections - drug therapy Coronaviruses Corticoids Corticosteroids COVID-19 COVID-19 Drug Treatment Double-Blind Method Emergency medical services Female Health hazards Health services Humans Infections Infusions, Intravenous Interferon Intravenous administration Laboratories Lopinavir Male Medical research Medical treatment Mercury Middle Aged Middle East respiratory syndrome Negative Results Nucleoside analogs Oxygen Oxygen content Pandemics Partial pressure Patients Pneumonia Pneumonia, Viral - drug therapy R&D Randomization Research & development Respiratory diseases Ritonavir RNA polymerase SARS-CoV-2 Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Statistical analysis Statistical significance Ventilators Viral diseases

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7190303

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7190303

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections